India Drug-Pricer Seeks Input From State Authorities On Local Diseases
This article was originally published in PharmAsia News
India's drug-pricing authority has requested individual state regulators to list the most common drugs for regional diseases and expensive drugs that could be placed under national price controls.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.